Published in Mol Pharm on March 02, 2015
Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. J Nanobiotechnology (2015) 0.79
Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Devel Ther (2016) 0.77
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. Mol Pharm (2016) 0.75
Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients. J Cancer (2016) 0.75
Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma. Pharm Res (2015) 0.75
Tackling breast cancer chemoresistance with nano-formulated siRNA. Gene Ther (2016) 0.75
Inhibition of cancer cell growth by ruthenium complexes. J Transl Med (2016) 0.75
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol (2010) 1.51
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers. J Antimicrob Chemother (2011) 1.25
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer (2010) 1.17
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model. Cancer Chemother Pharmacol (2008) 1.16
Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res (2009) 1.12
Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec. J Pharm Sci (2004) 1.11
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension. AAPS PharmSciTech (2005) 1.07
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One (2011) 1.07
In vitro and in vivo evaluation of topical formulations of spantide II. AAPS PharmSciTech (2005) 1.06
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release (2010) 1.05
AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One (2013) 1.03
Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharm Res (2006) 1.01
Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma. Clin Cancer Res (2004) 0.99
Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer. Mol Cancer Ther (2010) 0.98
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers. J Control Release (2012) 0.96
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. Anticancer Drugs (2007) 0.95
Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Release (2011) 0.94
Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors. Int J Cancer (2006) 0.92
Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. J Control Release (2013) 0.91
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Control Release (2002) 0.90
Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm (2002) 0.90
Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Pharm Res (2004) 0.90
Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application. Pharm Res (2012) 0.87
Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. PLoS One (2011) 0.86
Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J Pharm Sci (2004) 0.86
Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers. Antimicrob Agents Chemother (2013) 0.85
Formulation and in vitro evaluation of transdermal patches of melatonin. Drug Dev Ind Pharm (2004) 0.85
Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models. J Control Release (2013) 0.85
1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model. Eur J Pharm Sci (2013) 0.84
Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Deliv (2008) 0.83
Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis. J Pharm Pharmacol (2004) 0.81
Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. J Aerosol Med (2002) 0.81
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers. J Biomed Nanotechnol (2015) 0.80
Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin. J Pharm Pharmacol (2003) 0.80
Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1). PLoS One (2013) 0.80
EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer. Pharm Res (2014) 0.80
In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm (EPI-200) cultured human skin and hairless rats. Toxicol Lett (2006) 0.79
Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel. Pharm Res (2013) 0.79
Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats. J Drug Target (2011) 0.78
Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques. Nanomedicine (Lond) (2014) 0.78
Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals. Toxicology (2007) 0.78
Dermal microdialysis of inflammatory markers induced by aliphatic hydrocarbons in rats. Toxicol Lett (2008) 0.78
Brownian diffusion and surface kinetics of liposome and viral particle uptake by human lung cancer cells in-vitro. Ann Biomed Eng (2006) 0.78
Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption. J Drug Target (2014) 0.77
Opening up the optical imaging window using nano-luciferin. Pharm Res (2014) 0.77
Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM). Eur J Pharm Sci (2012) 0.77
Effect of jet fuels on the skin morphology and irritation in hairless rats. Toxicology (2002) 0.77
Unique Aspects of Coronary Artery Disease in Indian Women. Cardiovasc Drugs Ther (2015) 0.77
Chapter 9 - Nanoliposomal dry powder formulations. Methods Enzymol (2009) 0.76
Enhanced Percutaneous Delivery of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) Methane for Skin Cancer Chemoprevention. J Biomed Nanotechnol (2015) 0.76
Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity. Pharm Res (2015) 0.76
Passive droplet sorting using viscoelastic flow focusing. Lab Chip (2013) 0.76
Stability and degradation profiles of Spantide II in aqueous solutions. Eur J Pharm Sci (2005) 0.76
Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line. J Pharm Pharmacol (2004) 0.75
Effect of combination of hydrophilic and lipophilic permeation enhancers on the skin permeation of kahalalide F. J Pharm Pharmacol (2014) 0.75
Spontaneous deep venous thrombosis: An unrecognized entity with sorafenib. J Cancer Res Ther (2016) 0.75
Steep atomic dispersion induced by velocity-selective optical pumping. Opt Express (2008) 0.75
A rare complication in a case of multiple myeloma on therapy with thalidomide and dexamethasone--reversible posterior lobe leukoencephalopathy. Leuk Lymphoma (2006) 0.75
Evaluation of metered dose inhaler (MDI) formulations of ciclosporin. J Pharm Pharmacol (2007) 0.75
Primary pleuropulmonary synovial sarcoma with brain metastases in a paediatric patient: an unusual presentation. Adv Respir Med (2017) 0.75